dihexa clinicaltrials.gov Evidence out, ideology in. The FDA's quiet peptide pivot has nothing to do with the data and everything to do with whose side the regulator is choosing. On April 15, 2026, the Dihexa: Off FDA Category 2,

In a Phase II readout released in August 2022, the pharma touted a 15.6% drop in body weight in patients taking CagriSema, versus 5.1% in comparators on semaglutide alone and 8.1% in patients treated with only cagrilintide

2024-2025: 2025 Forbes Best-in-State Wealth Management Teams: Awarded January 2025

That is not a technicality

The Wnt pathway frizzled class receptor 8 (FZD8) expression rescued impaired HNSCC cells that were treated with c-MET inhibitor [92]

With frostbite, your body parts can be numb, stiff, and/or white or grayish-yellow

As you may (or may not) recall from your high school and college physics courses, heat loss can occur through a variety of mechanisms including conduction, convection, evaporation, and radiation (Table 2) An elderly patient who had an unwitnessed fall with a prolonged downtime can experience conductive heat loss with the floor